Cargando…

Bevacizumab for eye diseases – Legal, regulatory, and ethical overview

Vascular endothelial growth factor (VEGF) inhibitors, ranibizumab, aflibercept, and pegaptanib are approved treatments for certain eye diseases that occurs especially in the elderly. These drugs are mostly inaccessible due to their high cost. Bevacizumab is a VEGF inhibitor, approved for cancer trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jose, Vinu, Radhakrishna, Swetha, Pipalava, Parag, Singh, Inderjeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984021/
https://www.ncbi.nlm.nih.gov/pubmed/32029959
http://dx.doi.org/10.4103/ijp.IJP_413_19